Characterization of static adhesion of human platelets in plasma to protein surfaces in microplates

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 3, 2009, Pages 197-206

  Eriksson, Andreas C ^a   Whiss, Per A ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Adhesion receptor; Antiplatelet agents; Autocrine signalling; Platelet adhesion; Platelet assay

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ABCIXIMAB; ADENOSINE DIPHOSPHATE; ALBUMIN; ALPHA2B BETA3 INTEGRIN; ANTIBODY; BM 531; CANGRELOR; COLLAGEN; EPTIFIBATIDE; FIBRINOGEN; INTEGRIN; PLASMA PROTEIN; THROMBOXANE A2; TIROFIBAN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; LABORATORY TEST; MICROPLATE; PLASMA; PLATE COUNT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ALBUMINS; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; COLLAGEN; FIBRINOGEN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PEPTIDES; PLASMA; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PROTEINS; PURINERGIC P2 RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2; THROMBOXANE A2; TYROSINE;

EID: 67649630516     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328327353d     Document Type: Article

References (38)

1. Bou-Gharios G, Ponticos M, Rajkumar V, Abraham D. Extra-cellular matrix in vascular networks. Cell Prolif 2004; 37:207-220.
2. Santoro SA. Identification of a 160,000 Dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986; 46:913-920.
3. Staatz WD, Rajpara SM, Wayner EA, Carter WG, Santoro SA. The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J Cell Biol 1989; 108: 1917-1924.
4. Santoro SA, Rajpara SM, Staatz WD, Woods VL Jr. Isolation and characterization of a platelet surface collagen binding complex related to VLA-2. Biochem Biophys Res Commun 1988; 153:217-223.
5. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999; 274:29019-29024.
6. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003; 102:449-461.
7. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008; 28:403-412.
8. Berndt MC, Shen Y, Dopheide SM, Gardiner EE, Andrews RK. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001; 86:178-188.
9. Takagi J. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins. Biochem Soc Trans 2004; 32:403-406.
10. Bennett JS. Platelet-fibrinogen interactions. Ann N Y Acad Sci 2001; 936:340-354.
11. Santoro SA, Walsh JJ, Staatz WD, Baranski KJ. Distinct determinants on collagen support alpha 2 beta 1 integrin-mediated platelet adhesion and platelet activation. Cell Regul 1991; 2:905-913.
12. Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, et al. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20:2120-2130.
13. Auger JM, Kuijpers MJ, Senis YA, Watson SP, Heemskerk JW. Adhesion of human and mouse platelets to collagen under shear: a unifying model. FASEB J 2005; 19:825-827.
14. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994; 216:444-450.
15. Eriksson AC, Whiss PA. Measurement of adhesion of human platelets in plasma to protein surfaces in microplates. J Pharmacol Toxicol Methods 2005; 52:356-365.
16. Eriksson AC, Whiss PA, Nilsson UK. Adhesion of human platelets to albumin is synergistically increased by lysophosphatidic acid and adrenaline in a donor-dependent fashion. Blood Coagul Fibrinolysis 2006; 17:359-368.
17. Axelsson S, Hagg S, Eriksson AC, Lindahl TL, Whiss PA. In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation. Clin Exp Pharmacol Physiol 2007; 34:775-780.
18. Eriksson AC, Lotfi K, Whiss PA. Enhanced platelet adhesion in essential thrombocythemia assessed by a novel platelet function assay. Hematol J 2005; 90 (Suppl 2):260.
19. Eriksson AC, Jonasson L, Hedback B, Whiss PA. Monitoring platelet inhibiting treatment in coronary heart disease by static platelet adhesion. Atheroscler Suppl 2007; 8:189.
20. Eriksson AC, Nilsson UK, Whiss PA. The extracellular ion environment modulates platelet adhesion after lysophosphatidic acid treatment in vitro. Atheroscler Suppl 2006; 7:90.
21. Dogne JM, Rolin S, de Leval X, Benoit P, Neven P, Delarge J, et al. Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531. Cardiovasc Drug Rev 2001; 19:87-96.
22. Moroi M, Okuma M, Jung SM. Platelet adhesion to collagen-coated wells: analysis of this complex process and a comparison with the adhesion to matrigel-coated wells. Biochim Biophys Acta 1992; 1137:1-9.
23. Hwang DL, Yen CF, Nadler JL. Effect of extracellular magnesium on platelet activation and intracellular calcium mobilization. Am J Hypertens 1992; 5:700-706.
24. Bergkvist M, Carlsson J, Oscarsson S. Surface-dependent conformations of human plasma fibronectin adsorbed to silica, mica, and hydrophobic surfaces, studied with use ofatomic force microscopy.J Biomed Mater Res A 2003; 64:349-356.
25. Kim J, Somorjai GA. Molecular packing of lysozyme, fibrinogen, and bovine serum albumin on hydrophilic and hydrophobic surfaces studied by infrared-visible sum frequency generation and fluorescence microscopy. J Am Chem Soc 2003; 125:3150-3158.
26. Baugh L, Vogel V. Structural changes of fibronectin adsorbed to model surfaces probed by fluorescence resonance energy transfer. J Biomed Mater Res A 2004; 69:525-534.
27. Farndale RW. Collagen-induced platelet activation. Blood Cells Mol Dis 2006; 36:162-165.
28. Lu X, Williams JA, Deadman JJ, Salmon GP, Kakkar VV, Wilkinson JM, et al. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins. Biochem J 1994; 304 (Pt 3):929-936.
29. Patel Y, Rahman S, Siddiqua A, Wilkinson JM, Kakkar VV, Authi KS. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Thromb Haemost 1998; 79:177-185.
30. Schror K,Weber AA. Comparative pharmacology of GPIIb/IIIa antagonists. J Thromb Thrombolysis 2003; 15:71-80.
31. Hornby EJ, Brown S, Wilkinson JM, Mattock C, Authi KS. Activation of human platelets by exposure to a monoclonal antibody, PM6/248, to glycoprotein IIb-IIIa. Br J Haematol 1991; 79:277-285.
32. Gogstad GO, Brosstad F, Krutnes MB, Hagen I, Solum NO. Fibrinogen-binding properties of the human platelet glycoprotein IIb-=IIIa complex: a study using crossed-radioimmunoelectrophoresis. Blood 1982; 60:663-671.
33. Smith EB, Staples EM. Distribution of plasma proteins across the human aortic wall: barrier functions of endothelium and internal elastic lamina. Atherosclerosis 1980; 37:579-590.
34. Stastny JJ, Fosslien E. Quantitative alteration of some aortic intima proteins in fatty streaks and fibro-fatty lesions. Exp Mol Pathol 1992; 57:205-214.
35. Park K, Mao FW, Park H. Morphological characterization of surface-induced platelet activation. Biomaterials 1990; 11:24-31.
36. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 1987; 69:625-628.
37. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61:99-110.
38. Canobbio I, Balduini C, Torti M. Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 2004; 16:1329-1344.